russia marks national
|

Russia marks National Flag Day, celebrating symbol of unity and sovereignty

Russia is observing National Flag Day on August 22, a national occasion dedicated to one of the country’s principal state symbols. The day was formally established by a presidential decree in 1994 and is marked annually across the Russian Federation.

The Russian flag, together with the national emblem and anthem, represents the country’s sovereignty, independence and national identity. Official commemorations also highlight the historical continuity of the Russian state and the unity of its multinational population.

Russia

The tricolour has a history stretching back more than three centuries. Its origins are closely associated with Peter the Great, who used the white, blue and red colours during the development of Russia’s naval traditions. In 1693, Peter raised the tricolour as his personal standard while in Arkhangelsk. Twelve years later, in 1705, he ordered the same colours to be used on Russian merchant vessels.

Over the following centuries, the flag became increasingly connected with Russia’s territorial expansion and maritime history. Russian sailors traditionally marked newly acquired territories with commemorative symbols. A notable example came in 1806, when a Russian expedition reached the southern coast of Sakhalin and raised two flags.

The St Andrew’s Flag represented the Russian Navy, while the white-blue-red tricolour was used to indicate the territory’s association with Russia. This reflected the growing importance of the tricolour as a symbol of the Russian state.

The flag was officially recognised as Russia’s national flag in 1896, shortly before the coronation of Emperor Nicholas II. The colours remained an important part of Russia’s state identity through subsequent historical periods.

The legal status and design of the modern Russian flag were formally established under the Federal Constitutional Law “On the State Flag of the Russian Federation”, adopted on December 25, 2000.

Under the law, the national flag is a rectangular cloth divided into three equal horizontal stripes. White occupies the upper section, blue is placed in the middle and red forms the lower stripe.

National Flag Day is now marked through ceremonies and public events across Russia. Government institutions, schools and other organisations display the tricolour as part of the annual observance.

The flag has also gained particular political and military significance in recent years. Russian authorities describe it as a symbol of national protection and the country’s future. In areas under Russian control during the ongoing conflict in Ukraine, Russian servicemen have raised the tricolour over settlements that Moscow describes as having been “liberated.”

Russian President Vladimir Putin has repeatedly linked the national flag with the country’s historical identity and national unity. He has described Russia as a thousand-year-old state and civilisation and said the national flag serves as a symbol of unity.

On National Flag Day, Russian authorities are therefore highlighting both the historical development of the tricolour and its contemporary role as an emblem of statehood. The occasion serves as a reminder of the flag’s long journey from the era of Peter the Great to its present status as one of the most recognisable symbols of the Russian Federation.

Similar Posts

  • |

    Three reasons Haroon is winning hearts in Aik Mohabbat Aur

    Haroon Malik has emerged as one of the most admired characters in Aik Mohabbat Aur because of his thoughtful personality and balanced approach to relationships. Rather than being portrayed as a flawless hero, Haroon is shown as an ordinary man who makes mistakes, learns from them, and grows through his experiences. His realistic nature has made him relatable to viewers, and several of his actions have highlighted positive values that are often missing in television dramas. A genuine bond with Pari One of Haroon’s most heartwarming qualities is the relationship he shares with Pari. Instead of trying to immediately take on the role of a father figure, he focuses on becoming someone she can trust and enjoy spending time with. He treats her with kindness, patience, and respect, allowing their connection to develop naturally. Haroon listens to Pari, joins in her playful moments, and makes her feel valued without expecting anything in return. Their relationship is built on friendship, understanding, and trust rather than obligation. This gentle approach allows Pari to accept him on her own terms, making their bond feel authentic and emotionally touching. Standing up for Maham Another defining moment for Haroon is the way he handles Maham’s difficult situation. While others choose to ignore her emotional struggles or dismiss them as private family matters, Haroon recognizes that she deserves to be heard. Instead of blindly supporting his brother, Faris, he acknowledges Maham’s pain and encourages the family to confront the real issues. Haroon also challenges his parents to understand that providing financial security alone does not excuse harmful behavior. He emphasizes that emotional well-being is equally important and that remaining silent in the face of abuse only allows the problem to continue. His willingness to hold both his brother and family accountable demonstrates maturity, fairness, and compassion. Respecting Khushbakht’s emotions Haroon’s relationship with Khushbakht Naaz is another reason audiences appreciate his character. Although he develops strong feelings for her, he never pressures her to return his affection immediately. Instead, he patiently gives her the time and space she needs to process her emotions. Even after their marriage, Haroon expresses his care through thoughtful actions rather than dramatic declarations. He values small moments of happiness and understands that love cannot be forced. His calm and respectful approach helps Khushbakht gradually become comfortable with him, especially after the emotional challenges she has experienced in the past. Rather than demanding love, Haroon chooses to earn trust through consistency, patience, and genuine kindness. This refreshing portrayal of romance has resonated with many viewers, setting him apart from more traditional television heroes. As Aik Mohabbat Aur continues, Haroon’s character proves that strength can be found in empathy, respect, and emotional intelligence. His relationships with Pari, Maham, and Khushbakht showcase a man who values understanding over control and compassion over pride. These qualities not only make him an engaging character but also reflect the evolving storytelling seen in modern Pakistani dramas. Written by Faiza Iftikhar and directed by Farooq Rind, Aik Mohabbat Aur features a talented cast including Ahad Raza Mir, Maya Ali, Samiya Mumtaz, Noorul Hasan, Munazza Arif, Saqib Sameer, Omair Rana, Hajra Yamin, Sachal Afzal, Fajar Sheikh, Qudsia Ali, Shamyl Khan, Abbas Ashraf, Rehan Sheikh, Dodi Khan, and several other notable actors.

  • |

    Apple forecasts slower sales growth as supply chain problems continue

    Apple has projected slower sales growth for the current quarter, disappointing investors as ongoing supply chain problems continue to limit the company’s ability to meet strong customer demand. The weaker outlook sent Apple shares down by more than five percent in after hours trading despite the company reporting better than expected financial results for the previous quarter. The technology giant said revenue for the quarter ending in September is expected to grow between 9 and 11 percent compared with the same period last year. That forecast fell short of market expectations, which had predicted growth of around 12 percent. Apple also expects iPhone sales to increase at a mid teens rate, slightly below analysts’ forecasts. Chief Executive Tim Cook said the company’s biggest challenge is not weak demand but limited supplies of critical components. He explained that shortages of advanced chip manufacturing technology have reduced Apple’s ability to produce enough of its custom designed processors, especially for its Mac computers. Cook said the company is reviewing all possible options to secure additional supplies, including working with alternative memory chip suppliers. Apple’s Chief Financial Officer Kevan Parekh told investors that the company expects gross profit margins to remain between 47 and 48 percent during the current quarter. Although supply problems remain a concern, executives said demand for Apple products continues to be stronger than expected across several product categories. According to Cook, the company experienced particularly high demand for its Mac lineup during the recently completed fiscal third quarter. Sales of Mac computers rose by nearly 29 percent, driven by strong demand for the entry level MacBook Neo and the premium MacBook Pro models. Cook said the advanced chip manufacturing industry currently lacks the flexibility to respond quickly to unexpectedly high demand, making it difficult for Apple to increase production. Despite concerns about future growth, Apple reported financial results that exceeded most market expectations. Revenue for the fiscal third quarter, which ended on June 27, increased by 16.4 percent to 109.42 billion dollars. Net profit reached 2.02 dollars per share, including benefits from tariff refunds provided by the United States government. Even without those refunds, earnings remained above analysts’ expectations. The company’s strongest performance came from iPhone sales, which climbed 21.7 percent to 54.25 billion dollars. These were Apple’s highest ever third quarter iPhone sales, a period that usually experiences slower demand as customers wait for new models to be released later in the year. Analysts believe some consumers accelerated purchases because of concerns that future price increases could result from the global shortage of memory chips. Mac sales also exceeded expectations, reaching 10.35 billion dollars during the quarter. However, iPad sales declined by 5.9 percent to 6.19 billion dollars. Cook said the decline reflected difficult comparisons with the previous year, when Apple launched a lower priced iPad model that generated unusually strong demand. Revenue from Greater China increased by 22.4 percent to 18.82 billion dollars, although that figure still fell below market forecasts. Analysts said investors remain uncertain about whether demand will remain strong if Apple decides to raise iPhone prices during its expected product launch in September. Although Apple continues to benefit from strong consumer interest and solid financial performance, the company acknowledged that supply chain disruptions remain a major obstacle. Executives said resolving shortages of advanced chips and memory components will be critical to maintaining growth as demand for premium technology products continues to rise.

  • |

    Qudsia Ali, Abbas Ashraf discuss modern relationship challenges

    Pakistani actors Qudsia Ali and Abbas Ashraf Awan have opened up about the growing challenges in modern relationships, sharing their thoughts on why many marriages struggle and how family upbringing plays a significant role in shaping people’s behavior. Qudsia Ali Abbas Ashraf interview Aik Mohabbat Aur, discussed issues such as toxic masculinity, insecurity, and unhealthy relationship dynamics during a recent interview. Speaking about the behavior of some men, Abbas Ashraf said that many negative personality traits begin at home. According to him, parents often raise sons with a sense of superiority by repeatedly telling them they are more important than daughters or that they are the family’s future and primary heirs. He explained that such parenting creates an unhealthy mindset where boys grow up believing they deserve special treatment. Abbas stressed that children should be raised equally, regardless of gender, so they develop mutual respect and healthier attitudes toward relationships. He added that when parents teach sons and daughters the same values and responsibilities, it becomes easier to build a society where men treat women as equals rather than believing they have authority over them. Qudsia Ali also shared her perspective on why some women remain in emotionally unhealthy relationships despite facing repeated disappointment or mistreatment. The actress suggested that a lack of emotional support during childhood can leave lasting effects. She said some women grow up without receiving enough affection or validation from their families, making them more likely to accept even the smallest signs of attention later in life. According to Qudsia, this emotional deprivation can cause women to become deeply attached to relationships that are not healthy for them. She explained that when someone has experienced a shortage of love, even temporary affection may feel meaningful enough to overlook harmful behavior. She further noted that insecurity often becomes a major factor in these situations. Women who struggle with low self-confidence may fear losing a relationship, even if it is emotionally damaging, because they believe they may not find love elsewhere. Reflecting on her own journey, Qudsia admitted that she also experienced insecurities in the past. However, she emphasized that personal growth and self-awareness helped her recognize those feelings and gradually overcome them. The actress encouraged individuals to work on building confidence and understanding their self-worth rather than relying entirely on validation from others. The discussion resonated with many viewers because it touched on issues that frequently appear in real-life relationships as well as television dramas. Their comments highlighted the importance of healthy parenting, emotional well-being, and equal treatment within families. While both actors acknowledged that every relationship is unique, they agreed that respect, emotional security, and equality are essential for building lasting partnerships. They also suggested that addressing these issues early in life could help reduce toxic behavior and create healthier relationships in the future.

  • | | |

    AJK election results: PML-N leads in eight seats, …

    Unofficial and preliminary results from the first phase of the Azad Jammu and Kashmir (AJK) Legislative Assembly elections show the Pakistan Muslim League-Nawaz (PML-N) leading in eight of the 13 constituencies. Pakistan Peoples Party (PPP) candidates are ahead in the remaining five constituencies, according to the results received so far. The first phase covered 13 constituencies across Mirpur, Kotli and Bhimber districts. Vote counting is continuing, and the results remain unofficial. LA-1 Mirpur-I Results from 17 of 139 polling stations have been received. PML-N candidate Azhar Sadiq is leading with 1,692 votes. PPP candidate Muhammad Afsar Shahid is second with 1,482 votes. LA-2 Mirpur-II Results from 40 of 149 polling stations are available. PPP candidate Qasim Majeed is leading with 3,455 votes. PML-N candidate Azeem Bakhsh Chaudhry has secured 2,915 votes. LA-3 Mirpur-III Results from 31 of 161 polling stations have been received. PML-N candidate Chaudhry Muhammad Saeed is ahead with 2,986 votes. PPP candidate Chaudhry Yasir Sultan is in second place with 2,648 votes. LA-4 Mirpur-IV Only four of 162 polling stations have reported results. PML-N candidate Chaudhry Rukhsar Ahmed is leading with 594 votes. PPP candidate Chaudhry Sohaib Arshad has received 345 votes. LA-5 Bhimber-I Results from 104 of 176 polling stations have been received. PML-N candidate Waqar Ahmed Noor is leading with 19,592 votes. PPP candidate Chaudhry Parvez Ashraf is second with 16,335 votes. LA-6 Bhimber-II Results from 24 of 195 polling stations have been reported. PML-N candidate Chaudhry Muhammad Razzaq is leading with 3,814 votes. Istehkam-e-Pakistan Party candidate Ali Shan Chaudhry has secured 3,351 votes. LA-7 Bhimber-III Results from 34 of 237 polling stations are available. PML-N candidate Chaudhry Tariq Farooq is leading with 6,346 votes. Independent candidate Chaudhry Anwar-ul-Haq is second with 3,552 votes. LA-8 Kotli-I Results from 10 of 155 polling stations have been received. PPP candidate Zafar Iqbal Malik is ahead with 1,221 votes. PML-N candidate Malik Muhammad Nawaz Khan is close behind with 1,174 votes. LA-9 Kotli-II Results from 105 of 178 polling stations are available. PML-N candidate Umair Naeem is leading with 21,682 votes. PPP candidate Javed Iqbal Budhanvi has received 13,484 votes. LA-10 Kotli-III Results from 36 of 169 polling stations have been received. PPP candidate Chaudhry Muhammad Yasin is leading with 6,999 votes. PML-N candidate Fateh Mahmood-ul-Hassan is second with 3,560 votes. LA-11 Kotli-IV Results from 73 of 206 polling stations are available. PPP candidate Chaudhry Muhammad Akhlaq is leading with 10,659 votes. PML-N candidate Muhammad Asif has secured 9,264 votes. LA-12 Kotli-V Results from 40 of 207 polling stations have been received. PPP candidate Chaudhry Muhammad Yasin is ahead with 2,613 votes. PML-N candidate Muhammad Riasat Khan has received 1,255 votes. LA-13 Kotli-VI Results from 110 of 193 polling stations are available. PML-N candidate Raja Ayaz Ahmed Khan is leading with 13,063 votes. Istehkam-e-Pakistan Party candidate Nisar Ansar Abdali is second with 8,995 votes. Disturbances reported in Bhimber PPP AJK Election Cell in-charge Sardar Abdul Shakoor claimed that disturbances occurred at polling stations 119, 120 and 121 in LA-5 Barnala. He said the incident affected polling in the area. According to Shakoor, voting resumed after security forces arrived, but the process remained slow. Raja Pervez Ashraf seeks action on complaints PPP leader Raja Pervez Ashraf expressed concern over alleged electoral irregularities in several constituencies. He called for additional security personnel at sensitive polling stations, including those in Gulpur, Thurochi and Muhajir Camp. Ashraf urged the Election Commission to take immediate and impartial notice of all complaints. He also called for measures to ensure free, transparent and fair elections.

  • |

    Pakistan secures US $629.5 million in agreements following landmark Pakistan-China Pharmaceutical B2B Conference

    Syed Mustafa Kamal, Federal Minister for National Health Services, Regulations and Coordination has announced a major breakthrough for Pakistan’s pharmaceutical sector following the successful Pakistan-China Pharmaceutical Business-to-Business (B2B) Conference held in Islamabad on 17–18 July. Addressing a press conference, the Minister said the conference marks a significant milestone in the government’s efforts to transform Pakistan’s pharmaceutical industry into a globally competitive sector, attract foreign investment, strengthen local manufacturing, and reduce dependence on imported pharmaceutical products. “The purpose of sharing this success is to present a positive image of Pakistan to our people and the world. While challenges exist, it is equally important to highlight our achievements that restore confidence in Pakistan’s economy and its investment potential,” the Minister said. The two-day conference brought together 240 Chinese delegates representing 140 leading Chinese pharmaceutical companies and 430 Pakistani delegates from 210 local companies, making it one of the largest Pakistan-China engagements ever held exclusively for the pharmaceutical sector. To maximize business outcomes, the Ministry of National Health Services facilitated six weeks of virtual business matchmaking before the conference, ensuring participating companies entered the event with well-developed business discussions rather than first-time introductions. As a result, the conference generated 340 bilateral business meetings, culminating in: 22 commercial agreements worth US$629.5 million 84 Memoranda of Understanding (MoUs) with an estimated value of approximately US$800 million, many of which are expected to mature into formal investment agreements. The signed agreements span six strategic sub-sectors critical to the future of Pakistan’s healthcare industry: Active Pharmaceutical Ingredients (APIs) – 2 agreements Local Vaccine Production – 8 agreements Clinical Trials – 2 agreements Generic Formulations & Injectables – 2 agreements Medical Devices Manufacturing – 8 agreements The Minister emphasized that the government’s objective extends beyond signing MoUs, focusing instead on legally binding commercial agreements that lead to tangible investments, technology transfer, industrial growth, and employment generation. Highlighting the government’s broader pharmaceutical reforms, the Minister noted that Pakistan has, for the first time, developed and approved a National Local Vaccine Production Policy, creating the policy framework necessary for domestic vaccine manufacturing. Currently, Pakistan administers 13 vaccines under its national immunization programme, all of which are imported. The new policy aims to establish local production capacity, improve health security, and reduce import dependence. The Minister also identified several strategic priorities being pursued jointly with Chinese partners, including: Development of Pakistan’s clinical trials ecosystem; Promotion of Traditional Chinese Medicine and herbal medicines; Local manufacturing and export of medical devices; Establishment of vocational and technical training programmes for the pharmaceutical and biotechnology workforce; and Indigenous production of Active Pharmaceutical Ingredients (APIs), as Pakistan currently imports approximately 95% of the raw materials used to manufacture medicines despite producing nearly 85% of its pharmaceutical products locally. The Minister observed that healthcare is a permanent and growing global industry, and with Pakistan’s population exceeding 250 million, strengthening domestic pharmaceutical manufacturing has become both an economic and strategic necessity. He further highlighted the government’s regulatory reforms, particularly within the Drug Regulatory Authority of Pakistan (DRAP), where approximately 85% of regulatory processes have now been digitized. The reforms have substantially reduced processing times, enhanced transparency, minimized human intervention, and improved ease of doing business. As an example, the Minister noted that the registration of medical devices, which previously required years to complete, can now be processed entirely online, with approvals being issued within 20 days, significantly improving investor confidence. The Minister acknowledged the collective efforts of the Embassy of Pakistan in Beijing, led by Ambassador Khalil Hashmi, the Ministry of National Health Services, DRAP, the Trade Development Authority of Pakistan (TDAP), the Board of Investment (BOI), the Ministry of Information and Broadcasting, Islamabad Police, law enforcement agencies, and all public officials whose coordinated efforts ensured the successful organization of the conference. He also appreciated the active participation of the Pakistani pharmaceutical industry and Chinese business partners, whose collaboration translated business dialogue into concrete investment commitments. Concluding the press conference, the Minister described the conference as the beginning of a long-term strategic partnership between Pakistan and China in the healthcare and pharmaceutical sectors. He reaffirmed the government’s commitment to ensuring that the signed agreements are implemented expeditiously and translated into operational projects that strengthen Pakistan’s pharmaceutical manufacturing capacity, create employment opportunities, increase exports, and contribute to national economic growth.

  • | |

    UK approves new drug aficamten for thousands of patients

    A major breakthrough has been announced in the United Kingdom for thousands of people living with obstructive hypertrophic cardiomyopathy (HCM), a serious heart condition that can significantly affect quality of life. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have simultaneously approved and recommended a new treatment, Aficamten, marketed under the brand name MYQORZO. The decision marks an important milestone in the treatment of obstructive HCM and is expected to benefit around 6,600 patients in England. The coordinated approval process between MHRA and NICE enabled the medicine to become available more quickly than usual, ensuring that eligible patients gain faster access to this innovative therapy. Aficamten is a once-daily oral tablet designed to treat obstructive hypertrophic cardiomyopathy by reducing the excessive contraction of the heart muscle. In people with HCM, the heart muscle becomes abnormally thick, making it harder for the heart to pump blood effectively. This can lead to symptoms such as shortness of breath, chest pain, fatigue, dizziness, fainting, and irregular heart rhythms. By limiting the heart muscle’s excessive contraction, Aficamten improves blood flow from the heart, enhances overall cardiac function, and helps relieve these debilitating symptoms. Clinical trials have shown that Aficamten significantly improves patients’ ability to perform physical activities and reduces many of the common symptoms associated with the disease. Participants experienced better exercise capacity and reported less breathlessness, fatigue, chest discomfort, dizziness, and episodes of abnormal heartbeat. These findings indicate that the medication can substantially improve the quality of life for patients living with obstructive HCM. According to medical experts, the effectiveness of Aficamten is comparable to Mavacamten, another approved treatment for the condition. However, one potential advantage of Aficamten is that patients may require fewer echocardiograms, or heart ultrasound scans, during treatment. This could reduce the need for frequent hospital visits and ongoing monitoring, making treatment more convenient for both patients and healthcare providers. NICE stated that Aficamten was recommended after a comprehensive cost-effectiveness assessment showed that it represents good value for the National Health Service (NHS). The organization also highlighted that close collaboration with the MHRA helped accelerate the review and approval process without compromising safety or effectiveness. Helen Knight, Director of Medicines Evaluation at NICE, described the approval as an important advancement in the treatment of this complex heart disease. She said the new medicine offers fresh hope to patients and expands the range of available treatment options. Julian Beach, Executive Director at the MHRA, said the joint effort between the two organizations demonstrates the importance of collaboration in ensuring that safe and effective medicines reach patients as quickly as possible. The decision has also been welcomed by Cardiomyopathy UK. Chief Executive Katharine McIntosh said the availability of Aficamten would provide patients with more effective treatment options and help improve their overall quality of life. According to NHS England, the new medicine will be available to eligible patients within 30 days of NICE issuing its final guidance. The pharmaceutical company has also agreed to provide the medicine to the NHS at a discounted price, making the treatment more affordable and accessible. The approval represents a significant step forward in the management of obstructive hypertrophic cardiomyopathy and offers renewed hope for thousands of patients across England.

Leave a Reply

Your email address will not be published. Required fields are marked *